Infusion Pump Global Market Report 2024

The infusion pump market size has grown strongly in recent years. It will grow from $14.01 billion in 2023 to $15.16 billion in 2024 at a compound annual growth rate (CAGR) of 8.2%. The growth observed in the historical period can be attributed to factors such as an aging population, the prevalence of chronic diseases, trends in hospitalization, increasing rates of surgical procedures, and advancements in healthcare.

The infusion pump market size is expected to see strong growth in the next few years. It will grow to $20.9 billion in 2028 at a compound annual growth rate (CAGR) of 8.4%. The anticipated growth in the forecast period can be attributed to trends in home healthcare, the increasing prevalence of ambulatory care centers, the response to global health challenges, technological integration in healthcare, and the empowerment of patients. Major trends expected in the forecast period include the development of wearable infusion devices, the expansion of ambulatory infusion centers, customization for pediatric and geriatric patients, a focus on cost-effectiveness and efficiency, and the integration of artificial intelligence in infusion systems.

The infusion pump market is poised for growth, driven by an anticipated increase in the prevalence of chronic diseases. Chronic diseases, characterized by long-term health conditions progressing slowly over an extended period, such as cancer and diabetes, are on the rise due to changing lifestyles, inadequate physical activity, declining quality of life, and poor eating habits. Accurate dosing, precise fluid delivery, and customized treatments for these chronic diseases are facilitated by infusion pumps. According to the National Center for Biotechnology Information (NCBI), the global number of people with chronic diseases is projected to reach 142.66 million by 2050, up from 71.522 million in 2020. Additionally, the International Diabetes Federation forecasts 643 million diabetics worldwide by 2030 and 783 million by 2045. Thus, the increasing prevalence of chronic diseases is set to drive the growth of the infusion pump market.

The growth of the infusion pump market is further propelled by the increase in surgical procedures. Infusion pumps play a critical role in surgical settings, ensuring the precise and controlled delivery of medications, including anesthesia, pain management drugs, and specialized therapies. They contribute to intravenous fluid management, postoperative pain control, and the administration of parenteral nutrition. The rise in ambulatory and minimally invasive surgeries has heightened the demand for portable and ambulatory infusion pumps. For instance, in 2022, there was an 8.4% increase in cataract surgical procedures in the Czech Republic, totaling 142,670 procedures compared to 131,612 in 2021. Therefore, the surge in surgical procedures is a driving force for the growth of the infusion pump market.

Technological advancements are a key trend in the infusion pump market, with major companies focusing on developing innovative solutions to strengthen their positions. For example, in November 2022, Medtronic, a US-based medical device company, introduced the world's first and only insulin pump infusion set, MiniMed Quick-set Plus. This infusion set features cutting-edge components to lower insulin preservative loss and maintain insulin flow and stability, extending wear time by two times and enhancing the experience for diabetes patients.

Leading companies in the infusion pump market are also developing infusion management software to gain a competitive edge. Infusion management software is specialized computer programs designed to oversee and optimize the administration of fluids and medications through infusion pumps in healthcare settings. For instance, in June 2023, B. Braun Medical Inc. launched the DoseTrac Enterprise Infusion Management Software, offering real-time views and retrospective reporting features to effectively manage infusion pump fleets and associated data. The software can connect up to 40,000 pumps across multiple facilities, facilitating centralized management.

In March 2022, Fresenius Kabi, a Germany-based lifesaving medicines and technology company, acquired Ivenix Inc., a US-based manufacturer of intravenous drug infusion pump systems, enhancing Fresenius Kabi's comprehensive portfolio with advanced infusion pump technology, supplies, and accessories.

Major companies operating in the infusion pump market report are Becton, Dickinson and Company, Baxter International Inc., B. Braun Melsungen AG, ICU Medical Inc., Fresenius Kabi AG, Smiths Medical Inc., Medtronic plc, Moog Inc., Terumo Corporation, Insulet Corporation, Boston Scientific Corporation, Tandem Diabetes Care Inc., InfuTronix Solutions LLC, Micrel Medical Devices SA, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Pfizer Inc., Johnson & Johnson Services Inc., Roche Diagnostics Corporation, Siemens Healthineers AG, Mindray Medical International Limited, Ambu A/S, AngioDynamics Inc., Caesarea Medical Electronics Ltd., Owens & Minor Inc., Hospitech Respiration Ltd., IRadimed Corporation, Ivenix Inc., Sooil Development Co. Ltd., ZOLL Medical Corporation, Zyno Medical LLC.

North America was the largest region in the infusion pump market in 2023. The regions covered in the infusion pump market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the infusion pump market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary product types of infusion pumps include accessories and consumables, along with devices. Accessories and consumables encompass additional components designed to enhance the performance or functionality of the medical device. Various pump types are available, such as volumetric infusion pumps, insulin pumps, enteral infusion pumps, syringe infusion pumps, ambulatory infusion pumps, PCA pumps, and implantable infusion pumps. These pumps utilize technologies ranging from traditional infusion pumps to specialty infusion pumps. Applications for infusion pumps cover areas such as chemotherapy or oncology, diabetes management, gastroenterology, pain management or analgesia, pediatrics or neonatology, hematology, and others. They are used across diverse settings, including hospitals, ambulatory care settings, specialty clinics, and home care settings.

The infusion pump market research report is one of a series of new reports that provides infusion pump market statistics, including infusion pump industry global market size, regional shares, competitors with a infusion pump market share, detailed infusion pump market segments, market trends and opportunities, and any further data you may need to thrive in the infusion pump industry. This infusion pump market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.